3,849,597 Shares in Blue Owl Capital Inc. $OWL Purchased by Danica Pension Livsforsikringsaktieselskab

Danica Pension Livsforsikringsaktieselskab purchased a new stake in Blue Owl Capital Inc. (NYSE:OWL) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,849,597 shares of the company’s stock, valued at approximately $65,174,000. Danica Pension Livsforsikringsaktieselskab owned about 0.25% of Blue Owl Capital as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently bought and sold shares of the company. Parkside Financial Bank & Trust raised its position in shares of Blue Owl Capital by 117.0% in the 3rd quarter. Parkside Financial Bank & Trust now owns 1,608 shares of the company’s stock valued at $27,000 after purchasing an additional 867 shares in the last quarter. Headlands Technologies LLC bought a new stake in shares of Blue Owl Capital in the second quarter worth $51,000. Activest Wealth Management bought a new stake in shares of Blue Owl Capital in the third quarter worth $50,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Blue Owl Capital by 248.7% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,680 shares of the company’s stock valued at $90,000 after acquiring an additional 3,338 shares in the last quarter. Finally, Bessemer Group Inc. raised its holdings in Blue Owl Capital by 20.3% in the third quarter. Bessemer Group Inc. now owns 4,967 shares of the company’s stock valued at $84,000 after acquiring an additional 838 shares in the last quarter. Institutional investors and hedge funds own 35.85% of the company’s stock.

Blue Owl Capital News Summary

Here are the key news stories impacting Blue Owl Capital this week:

• Positive Sentiment: Independent bullish analysis argues the market panic over private credit is overblown; notes strong liquidity, conservative lending metrics, a $1.4B loan sale at ~99.7% of par, and large permanent‑capital fee streams — supports a near‑term valuation rebound. Read More.
• Positive Sentiment: Another bullish writeup says OWL’s discount to fair value looks “absurd” after recent declines, highlighting floating‑rate exposure, concentrated low‑LTV software loans, and resilient fundamentals — frames current price as a buying opportunity. Read More.
• Positive Sentiment: Strategic deal: Blue Owl partnered with Blackstone to take a minority stake in Atlas Holdings — a partnership that may expand deal flow and fee‑earning opportunities. Read More.
• Neutral Sentiment: Analyst action: Citizens Jmp lowered its price target from $26 to $23 but maintained a “market outperform” rating — still a bullish endorsement, though the cut trims upside expectations versus prior forecasts. Read More.
• Neutral Sentiment: Market roundup notes OWL rose even as sector‑wide private‑credit fears persist — suggests traders are distinguishing OWL’s balance‑sheet exposure from broader industry headlines. Read More.
• Neutral Sentiment: Comparative coverage and surveys (peer comparisons) provide context but contain limited new information likely to move the stock materially in the near term. Read More.
• Negative Sentiment: Reputational/regulatory risk: The FT reports Blue Owl tipped a UK mortgage lender into insolvency after uncovering “irregularities.” That headline raises potential reputational exposure and could invite regulatory scrutiny or litigation risk, which would weigh on sentiment until details/impacts are clarified. Read More.

Wall Street Analyst Weigh In

OWL has been the subject of several recent analyst reports. Raymond James Financial reissued a “strong-buy” rating on shares of Blue Owl Capital in a report on Thursday, February 19th. Oppenheimer reduced their price target on shares of Blue Owl Capital from $24.00 to $17.00 and set an “outperform” rating on the stock in a research report on Wednesday, March 4th. Wolfe Research set a $20.00 price target on Blue Owl Capital in a research note on Wednesday, January 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Blue Owl Capital in a report on Wednesday, January 21st. Finally, Zacks Research cut Blue Owl Capital from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 27th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Blue Owl Capital presently has an average rating of “Moderate Buy” and an average target price of $17.69.

Blue Owl Capital Price Performance

OWL stock opened at $9.16 on Wednesday. The firm has a market cap of $14.23 billion, a price-to-earnings ratio of 91.56, a PEG ratio of 0.78 and a beta of 1.15. Blue Owl Capital Inc. has a 1-year low of $8.55 and a 1-year high of $21.88. The firm has a fifty day moving average price of $12.55 and a two-hundred day moving average price of $14.94.

Blue Owl Capital (NYSE:OWL) last posted its quarterly earnings results on Thursday, February 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Blue Owl Capital had a net margin of 2.75% and a return on equity of 20.93%. The company had revenue of $701.47 million for the quarter, compared to the consensus estimate of $712.75 million. As a group, analysts expect that Blue Owl Capital Inc. will post 0.92 EPS for the current fiscal year.

Blue Owl Capital Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 20th were given a $0.225 dividend. The ex-dividend date was Friday, February 20th. This represents a $0.90 annualized dividend and a yield of 9.8%. Blue Owl Capital’s dividend payout ratio is 900.00%.

Blue Owl Capital Company Profile

Blue Owl Capital is a global alternative asset manager that focuses on private credit, direct lending and equity-related strategies for institutional investors. Headquartered in New York, the firm develops and manages a range of private markets products designed to provide capital solutions to middle-market and larger corporate borrowers, as well as liquidity and partnership arrangements with private equity firms and other alternative managers.

Its core activities include direct lending and credit strategies that provide senior, unitranche and other structured loan products to companies across industries.